Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|November 20, 2022
Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitorsRongyi Wang, Kohei Tsuji, Takuya Kobayakawa, et al.
Bioorganic & Medicinal Chemistry|November 6, 2020
Bivalent HIV-1 fusion inhibitors based on peptidomimeticsTakuya Kobayakawa, Kento Ebihara, Kohei Tsuji, et al.
Chemical & Pharmaceutical Bulletin|March 18, 2024
Effect of Two-Photon Excitation to 8-Azacoumarin Derivatives as Photolabile Protecting GroupsTakuya Kobayakawa, Hikaru Takano, Takahiro Ishii, et al.
Virology|December 29, 2022
Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38CKanako Matsuura, Mizuki Yamaura, Hiromi Sakawaki, et al.
Chemmedchem|February 12, 2026
CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry InhibitorsKohei Tsuji, Yutaro Miura, Takeo Kuwata, et al.
RSC Medicinal Chemistry|October 20, 2023
Development of anti-HBV agents targeting HBV capsid proteinsTakuya Kobayakawa, Masayuki Amano, Miyuki Nakayama, et al.
Bioorganic & Medicinal Chemistry|December 14, 2020
Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragmentKohei Tsuji, Rongyi Wang, Takuya Kobayakawa, et al.
Bioorganic & Medicinal Chemistry|October 28, 2018
Flexibility of small molecular CD4 mimics as HIV entry inhibitorsTakuya Kobayakawa, Nami Ohashi, Yuki Hirota, et al.
Bioorganic & Medicinal Chemistry|April 20, 2020
Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragmentKohei Tsuji, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, et al.
ACS Omega|September 22, 2025
SARS-CoV‑2 Main Protease Inhibitors Containing 5‑Substituted Benzothiazole-2-carbonyl Moieties at the P1' Site and Their DerivativesKohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, et al.
Pageof 5